Examiner Matos Negron Taina D (SPE)

3901-MATOS-NEGRON-TAINA-D

Employment Information

Art Unit:3901 — Drug, bio-affecting and body treating compositions
Group:3900 — UNKNOWN
Classes: 514 — Drug, bio-affecting and body treating compositions
544 — Organic compounds -- part of the class 532-570 series
424 — Drug, bio-affecting and body treating compositions
568 — Organic compounds -- part of the class 532-570 series
548 — Organic compounds -- part of the class 532-570 series
Phone:(571) 272-6013
Email:None
Location:None

Grant Rate and Difficulty Ranking

85
3-Year Grant rate: 43% over 143 cases
Difficulty: Very Hard
Difficulty Percentile: 85th

With Examiner Matos (SPE), you have a 43% chance of getting an issued patent by 3 years after the first office action. Examiner Matos (SPE) is a very hard examiner and in the 85th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Matos (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 3901

Examiner Matos (SPE)'s grant rate is lower than that of Art Unit 3901 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Matos (SPE) 1.6
Art Unit 3901 3.0

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...